Trial Condition(s):

Magnetic Resonance Imaging

Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients with symptoms of central nervous system (CNS) lesions

Bayer Identifier:

Trial_202-14_88492

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

July1987

December1987

Phase

Could I receive a placebo?

Products

Magnevist (Gadopentetate Dimeglumine, BAY86-4882)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Magnetic Resonance Imaging

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information